Documented security problems with compounded semaglutide consist of dosing glitches from incorrect compounding or mislabeling, contamination with microbes or other damaging substances through preparing, existence of impurities or unintended ingredients, use of non-pharmaceutical grade Energetic elements from unregistered suppliers, and inconsistent